1. Pancreatic cancer screening in high-risk individuals with germline genetic mutations 
Tomas DaVee, MD, MSCI, Emmanuel Coronel, MD, Charilaos Papafragkakis, MD, Sayam Thaiudom, MD, Gandhi Lanke, MD, Raja C. Chakinala, MD, Graciela M. Nogueras González, MPH, Manoop S. Bhutani, MD, William A. Ross, MD, Brian R. Weston, MD, Jeffrey H. Lee, MD, MPH 
Gastrointestinal Endoscopy 
Volume 87, Issue 6, Pages (June 2018)
DOI: /j.gie
Copyright © 2018 American Society for Gastrointestinal Endoscopy Terms and Conditions

2. Figure 1
Pancreatic abnormalities found in patients who were screened for pancreatic cancer. A, A 60-year-old woman with a BRCA1 mutation and 1 second-degree relative with pancreatic cancer. EUS showed a cyst in the head of the pancreas and hyperechoic strands and foci in the pancreas parenchyma with lobularity. B, A 63-year-old man with Peutz-Jeghers syndrome. EUS found numerous cysts in the entire pancreas.
Gastrointestinal Endoscopy  , DOI: ( /j.gie )
Copyright © 2018 American Society for Gastrointestinal Endoscopy Terms and Conditions

3. Figure 2
Percentage of patients analyzed by age range and test modality. All patients underwent screening by multiple modalities. A, Pancreatic cancer screening modality used and age range of patients. B, Age of patients as divided by screening modality. CA19-9, Carbohydrate antigen 19-9; MRI, magnetic resonance imaging.
Gastrointestinal Endoscopy  , DOI: ( /j.gie )
Copyright © 2018 American Society for Gastrointestinal Endoscopy Terms and Conditions